Abstracts tagged "Journal"

Abstract Number: 327 • 2019 ACR/ARP Annual Meeting
Presentation Order Bias in Rheumatology Journals: A Content Analysis
Sarah Stewart¹, Greg Gamble ², Andrew Grey ² and Nicola Dalbeth ², ¹University of Auckland, Auckland, Auckland, New Zealand, ²University of Auckland, Auckland, New Zealand
Background/Purpose: Presentation order can influence the prominence of an academic article. Earlier-listed items or those at the top of tables of contents are more likely…
Abstract Number: 252 • 2018 ACR/ARHP Annual Meeting
Publication Bias Regarding Scientific Studies about Fibromyalgia
Robert S. Katz¹, Lauren Kwan² and Frank Leavitt¹, ¹Rush University Medical Center, Chicago, IL, ²Rheumatology Associates S.C., Chicago, IL
Background/Purpose: It is estimated that approximately 5 million people in the United States suffer from Fibromyalgia. That's compared to 1.3 million adults with rheumatoid arthritis…
Abstract Number: 1145 • 2016 ACR/ARHP Annual Meeting
#Rheumjc: Impact of Invited Authors on a Twitter Based Rheumatology Journal Club
Isabelle Amigues¹, Paul Sufka², Suleman Bhana³, Jose Campos⁴ and Christopher Collins⁵, ¹Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, ²Rheumatology, HealthPartners, Saint Paul, MN, ³Crystal Run Healthcare, Middletown, NY, ⁴Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain, ⁵Medicine, MedStar Washington Hospital Center/ Georgetown University Medical Center, Washington, DC
Background/Purpose: Twitter is an increasingly popular platform for discussion and engagement among healthcare professionals. #RheumJC is a Twitter-based international rheumatology journal club which occurs approximately…
Abstract Number: 2217 • 2015 ACR/ARHP Annual Meeting
#Rheumjc: Development, Implementation and Analysis of an International Twitter-Based Rheumatology Journal Club
Christopher Collins¹, Paul Sufka², Jonathan S. Hausmann³, Arundathi Jayatilleke⁴, Jose Campos⁵ and Suleman Bhana⁶, ¹Rheumatology, Washington Hospital Center, Washington, DC, ²Rheumatology, HealthPartners, Saint Paul, MN, ³Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, ⁴Medicine, Division of Rheumatology, Drexel University College of Medicine, Philadelphia, PA, ⁵Rheumatology, Puerta de Hierro Majadahonda University Hospital, Madrid, Spain, ⁶Crystal Run Healthcare, Middletown, NY
Background/Purpose: Twitter is an increasingly popular platform for discussion and engagement amongst healthcare professionals. Here we describe the development, implementation and analysis of a rheumatology…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].